First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markers ...
Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback